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Abstract
Over 90% of genetic variants associated with complex human traits map to non-coding regions, 
but little is understood about how they modulate gene regulation in health and disease. One 
possible mechanism is that genetic variants affect the activity of one or more cis-regulatory 
elements leading to gene expression variation in specific cell types. To identify such cases, we 
analyzed ATAC-seq and RNA-seq profiles from stimulated primary CD4+ T cells in up to 105 
healthy donors. We found regions of accessible chromatin (ATAC-peaks) are co-accessible at 
kilobase and megabase resolution, consistent with the 3D chromatin organization measured by in 
situ Hi-C in T cells. 15% of genetic variants located within ATAC-peaks affected the accessibility 
of the corresponding peak (ATAC-QTLs). ATAC-QTLs have the largest effects on co-accessible 
peaks, are associated with gene expression, and are enriched for autoimmune disease variants. Our 
results provide insights into how natural genetic variants modulate cis-regulatory elements, in 
isolation or in concert, to influence gene expression.
Introduction
The vast majority of disease-associated loci identified through genome-wide association 
studies (GWAS)1–3 are located in non-coding regions of the genome, often distant from the 
nearest gene4. Quantitative trait loci (QTL) studies that associate genetic variants with 
molecular traits provide a framework for assessing the gene regulatory potential of disease-
associated variants. For example, a statistically significant number of GWAS loci are 
associated with gene expression (expression QTLs – eQTLs) across diverse cell types and 
states5–10, implicating gene regulation in determining disease risk11,12.
Genetic analysis of variation in chromatin state13–17 is a powerful approach for identifying 
single nucleotide polymorphisms (SNPs) that directly affect cis-regulatory activity18. In 
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lymphoblastoid cell lines, thousands of SNPs have been associated with DNase I 
hypersensitivity (measured by DNase-seq)19 and histone tail modifications (measured by 
ChIP-seq)20–22. Similarly, SNPs have been associated with variation in DNA methylation 
and histone tail modifications in resting primary immune cell types (neutrophils, monocytes 
and CD4+/CD45RA+ effector memory T cells)12. Most of the associated SNPs in these 
studies were also associated with nearby transcript abundance, suggesting the genetic 
perturbation of cis-regulatory activity as a determinant of gene expression 
variability11,12,19,21,23.
These studies have provided foundational resources for understanding the genetic basis of 
gene regulation in resting cells, but many disease states are associated with immune cell 
activation24,25. In particular, dysregulation of T cell homeostasis and activation are known to 
play a role in autoimmunity26,27, cancer28,29 and infectious diseases30, and hundreds of 
SNPs have been associated with gene expression during T cell activation and 
polarization10,31. Moreover, because both DNase-seq and ChIP-seq are laborious and require 
large cell numbers, it remains challenging to apply them to primary human cells at the scale 
required for genetic association.
Here, we optimized and performed Assay for Transposase Accessible Chromatin sequencing 
(ATAC-seq) on stimulated CD4+ T cells from 105 healthy individuals to characterize the 
extent of natural variability in chromatin state, identify its genetic basis, and assess its 
influence on gene expression. We further leveraged the variability between individuals to 
identify co-accessible chromatin regions and to relate those to genetic variation and 3D 
genome organization. Our work helps lay the foundation for the critical tasks of annotating 
cis-regulatory elements in primary human T cells and characterizing how genetic variation 
contribute to variability in gene regulation between individuals.
Results
Changes in T cell chromatin state in response to activation
We used ATAC-seq32 to assay CD4+ T cells in two different conditions: either unstimulated 
(Th), or stimulated in vitro using tetrameric antibodies against CD3 and CD28 for 48 hours 
(Thstim) (Fig. 1a). Aligned reads from six samples (five donors, one pair of donors were 
replicates) were pooled for each condition, yielding a total of 209 million reads for Thstim 
and 58 million for Th cells (Methods). Of these five donors, two are of East Asian, two are 
of African American and one is of European decent (Supplementary Fig. 1). There was a 
global increase in chromatin accessibility in response to stimulation, with 52,154 chromatin 
accessible peaks detected in Thstim (average width: 483 bp +/− 344 bp) and 36,487 in Th 
cells (average width of 520 bp +/− 319 bp) (MACS2, FDR < 0.05, Fig. 1a, b). 
Downsampling each Thstim sample to the same number of reads as the matching Th sample 
yielded a similar trend (24,665 Thstim vs. 17,313 Th peaks) suggesting the increased 
accessibility is not due to differences in sequencing depth. Of the 63,763 peaks identified in 
at least one condition, 27,446 are similarly accessible between the conditions (shared peaks), 
28,017 are more accessible in Thstim cells (Thstim-specific peaks) (FDR < 0.05), and 8,298 
are more accessible in Th cells (Th-specific peaks) (FDR < 0.05) (Fig. 1a, b, and 
Supplementary Table 1).
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Peaks of accessible chromatin are associated with distinctive genomic features and enriched 
for SNPs associated with autoimmune diseases. Compared to Th-specific peaks, Thstim-
specific peaks overlap a higher percentage of enhancers defined using H3K27Ac marks18 in 
αCD3/αCD28- (Th0, 6.9% vs. 2.6%) and phorbol myristate acetate (PMA)-stimulated CD4+ 
T cells (Thstim, 7.2% vs. 3.6%); and a lower percentage of enhancers in regulatory (Treg, 
1.4% vs. 4.0%), naïve (Tnaive, 1.2% vs. 4.9%) and IL17 producing CD4+ T cells (Th17, 3.2% 
vs. 4.6%) (Fig. 1c)18. Thstim-specific and shared peaks also overlap a higher percentage of 
SNPs associated with autoimmune diseases, including inflammatory bowel disease (IBD) 
(32% and 41% vs. 20%) and rheumatoid arthritis (21% and 27% vs. 13%) (Fig. 1d), 
highlighting the importance of profiling cells under stimulation to identify disease-relevant 
cis-regulatory elements.
Analyzing peaks of accessible chromatin in aggregate provides estimates of the frequencies 
and single-nucleotide resolution footprints of transcription factor (TF) binding32. Thstim-
specific peaks are enriched for genomic locations bound by TFs important for CD4+ T cell 
activation or differentiation, including members of the AP-1 super family (e.g., 36% contain 
a BATF binding site) and interferon regulatory factors (e.g., 15% contain a IRF4 binding 
site)33–35 (Fig. 2a, b). Thstim-specific peaks overlapping regions bound by both BATF and 
IRF4 (17.4% of peaks)34 reveal a different footprint compared to those overlapping regions 
bound by only one of the TFs (Fig. 2b, left). Conversely, shared peaks are enriched for 
regions bound by CTCF and BORIS (encoded by CTCFL), two transcriptional repressors 
known to maintain chromatin state independent of cell type and state33–35 (Fig. 2a), and 
their binding footprints are invariant of condition (Fig. 2b, right). ETS1 binding sites 
overlapping shared, Thstim-, and Th-specific peaks have distinct footprints and binding 
motifs: we observed the canonical ETS1 motif (5′-CACTTCCTGT-3′) in shared peaks, a 3′ 
extended motif (5′-CACTTCCTGTCA-3′) in Th-specific peaks, and a T/G to T (5′-
CACTTCCTGT-3′) substitution at the eighth position in Thstim-specific peaks, consistent 
with sequence motifs found at distal ETS1 binding sites (Fig. 2c)36. Th-specific peaks are 
more likely to overlap ETS/RUNX binding sites than shared or Thstim-specific peaks (OR = 
2.7 and 3.9; Fisher’s exact test, P-value < 2.2×10−16 and P-value < 2.2×10−16, respectively) 
(Fig. 2d), which could be due to an enrichment of Th-specific peaks for Treg enhancers 
known to be bound by the ETS/RUNX complex37,38. An additional 6,102 Thstim-specific 
(6.6% of intergenic regions) and 4,118 shared peaks (4.5% of intergenic regions) were 
located in non-coding regions, previously not annotated by H3K27Ac18,39, of which 53.5% 
and 35.6% overlap known binding sites for TFs in the AP-1 super family and IRF family, 
respectively. Thus, regions of accessible chromatin overlap both known enhancers and TF 
binding sites important for polarization-independent activation of T cells, consistent with our 
stimulation protocol, and in aggregate reveal high-resolution footprints distinguishing 
condition specific and combinatorial transcription factor binding.
Chromatin co-accessibility at multiple genomic scales
Because Thstim-peaks, including shared and Thstim-specific peaks, better overlap known T 
cell cis-regulatory elements and autoimmune disease loci, we next characterized the inter-
individual variability of chromatin accessibility only in stimulated T cells. We optimized the 
ATAC-seq protocol to profile stimulated CD4+ T cells (Supplementary Fig. 2; Methods) 
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from 105 healthy donors in the ImmVar Consortium10, all of European descent (Fig. 3a and 
Supplementary Fig. 1). We obtained a median of 37 million (MAD +/−13 million) reads per 
sample, from highly complex libraries with low mitochondrial DNA (mtDNA) 
contamination (average contamination < 3%, Supplementary Fig. 3). Using a pool of 4.2 
billion merged reads from all 105 individuals, we jointly called 167,140 peaks of accessible 
chromatin (heretoafter, ATAC-peaks) (MACS2, FDR < 0.05, Fig. 3a, b). These included 
85.1% of the 52,154 Thstim peaks identified in the initial set of six samples from five 
individuals with similar enrichment for GWAS loci (Pearson R = 0.65) and enhancer 
elements (Pearson R = 0.88) (Supplementary Fig. 4).
Leveraging the variability in ATAC-peaks across 105 individuals, we found patterns of co-
accessibility (defined as correlation between individual or sets of ATAC-peaks) at multiple 
genomic scales, recapitulating the 3D chromatin organization, as determined by domain-
resolution in situ Hi-C40 of stimulated CD4+ T cells pooled from another five donors 
(Supplementary Table 2, and Supplementary Fig. 5). At the resolution of 1 Mb bins, we 
observed significant intra-chromosomal co-accessibility, as measured by correlation of total 
counts of ATAC-peaks within each bin (Chr1: Fig. 3c, other chromosomes: Supplementary 
Fig. 6). These pairwise correlations are qualitatively similar to and quantitatively consistent 
with (Pearson R = 0.66) Hi-C interaction frequencies at the same resolution (Fig. 3d and 
Supplementary Fig. 6), likely reflecting variability in the signal (regions of accessible 
chromatin) to noise (regions of inaccessible chromatin) ratio across samples similar to 
observations in single cells32. At 100 kb resolution, pairwise correlations are also consistent 
with Hi-C interaction frequencies (Pearson R = 0.52, Supplementary Fig. 7).
We next characterized the co-accessibility between pairs of ATAC-peaks within each 1.5 Mb 
bin across the genome by linear regression (Fig. 3b, dashed black line, left). After 
accounting for sources of variation (Supplementary Tables 3 and 4), we found 2,158 pairs of 
co-accessible peaks enriched for those in close proximity (on average 514 kb apart), 
encompassing 2% (3,204/167,140) of ATAC-peaks (permutation FDR < 0.05, Fig. 3e, 
Supplementary Table 5, and Supplementary Fig. 8). The sequencing coverage of co-
accessible peaks is similar to that of all ATAC-peaks (Supplementary Fig. 9a), but they are 
individually more likely to overlap Tnaïve, Thstim, and Th17 enhancers (Supplementary Fig. 
10) and binding sites for three pioneering factors: NRF, NFY, and STAF (FDR < 0.05, 
Supplementary Fig. 11). Pairs of co-accessible peaks were more correlated when both peaks 
reside in the same contact domain (estimated from Hi-C interactions, Fig. 3f) and 80% 
consisted of peaks overlapping pairs of cis-regulatory annotations (e.g. enhancer/enhancer, 
enhancer/promoter, super enhancer/promoter; Fig. 3g). Finally, co-accessible peaks were 
enriched in annotated Thstim super-enhancer regions41 (Fig. 3h, Methods)41,42. These results 
suggest that chromatin co-accessibility may be determined by the 3D conformation of the 
genome and may correspond to coordinated regulation of multiple cis-regulatory elements, 
including known T cell enhancers and regions bound by pioneering factors.
Genetic variants associated with chromatin accessibility
We next defined the genetic basis of chromatin accessibility by associating ATAC-peaks 
with common SNPs (minor allele frequency > 0.05) across the 105 individuals. To maximize 
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statistical power, we analyzed only the 64,188 SNP-containing ATAC-peaks (Fig. 3b) and 
found 3,318 that were significantly associated with at least one SNP (RASQUAL43, P-value 
< 2.91×10−3, permutation FDR < 0.05) (Fig. 4a, Supplementary Fig. 12 and Supplementary 
Table 6). Each best-associated SNP we term a local ATAC quantitative trait locus (local-
ATAC-QTL) and the corresponding peak a local-ATAC-peak (Fig. 3b, middle). We estimate 
that 15% of the 64,188 peaks are associated with at least one local-ATAC-QTL using a 
method to estimate the proportion of null hypotheses while accounting for incomplete 
power44. Sequencing coverage of local-ATAC-peaks was similar to all ATAC-peaks 
(Supplementary Fig. 9b) and the estimated effects of local-ATAC-QTLs are correlated with 
their effects on H3K27AC ChIP-seq peaks in similar cell types12 (Supplementary Fig. 13.
Several lines of evidence support a model where local-ATAC-QTLs affect accessibility by 
perturbing cis-regulatory elements active in stimulated T cells. First, for the 1,428/3,318 
heritable local-ATAC-peaks determined by fitting a linear mixed model over SNPs +/− 500 
kb of each peak45 (mean h2 = 44%, GCTA FDR < 0.05), 81% of the heritability is explained 
by the corresponding local-ATAC-QTLs (Fig. 4b and Supplementary Tables 6 and 7; 
Methods). This suggests a genetic architecture where a single SNP is responsible for the 
majority of heritable variation. Second, compared to SNP-containing ATAC-peaks, local-
ATAC-peaks are preferentially located near transcription start and termination sites (Fig. 4c), 
are more enriched for T cell enhancers (P-value < 9.23×10−63, hypergeometric test; 
Supplementary Figure 14), and are more enriched for genomic regions bound by TFs 
involved in T cell development and activation (e.g. BATF, AP-1 and IRF) (Supplementary 
Figure 15). Applying deltaSVM46,47 to predict the effects of SNPs on TF binding for 903 
ATAC-QTLs located within 300 bp of the middle of the corresponding peaks, we found that 
almost half (45%) are predicted to strongly disrupt bindings for one of six (BATF, ETS1, 
IRF, RUNX1, SP1 and CTCF) TF binding sites (Fig. 4d). The effect sizes of local-ATAC-
QTLs are correlated with SNP motif disruption scores obtained by deltaSVM48 (Pearson R 
= 0.627, P-value < 2.33×10−98, Fig. 4e; Methods). For local-ATAC-peaks that overlap BATF, 
ETS1 and CTCF binding sites, differential accessibility between genotypes in the core 
motifs were observed at single nucleotide resolution, even though only 5% of the 
corresponding local-ATAC-QTLs directly alter the core motif sequences. This suggests that 
the genetic perturbation of TF binding – either directly by disrupting their sites, or more 
likely indirectly by first disrupting binding by other factors in the same cis-regulatory 
element – may be a major driver for the observed variation in chromatin accessibility across 
individuals (Fig. 4f and Supplementary Fig. 16). Note that the relation between the 
accessibility of local-ATAC-peaks and 3D chromatin organization is similar to that observed 
for SNP-containing ATAC-peaks in general (Fig. 4g). Both local-ATAC-peaks and SNP-
containing ATAC-peaks overlapping BATF and ETS motifs are enriched within Hi-C contact 
domains, whereas those overlapping CTCF motifs are enriched at the contact domain 
boundaries (Fig. 4g). These results are consistent with previous reports of CTCF enrichment 
at contact domain boundaries40,49–51.
Local-ATAC-peaks are more likely to overlap GWAS SNPs from autoimmune diseases than 
other SNP-containing ATAC-peaks (Supplementary Figure 17), providing a functional 
context for interpreting disease associations. Even though local-ATAC-peaks consist of only 
~5% of the SNP-containing ATAC-peaks, they overlap a much larger percentage of the loci 
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associated with autoimmune diseases including Celiac’s disease (28%), Crohn’s disease 
(22%), and rheumatoid arthritis (12%), an 8-fold (hypergeometric P-value < 4.34×10−7), 6-
fold (hypergeometric P-value < 8.58×10−17), and 5-fold (hypergeometric P-value < 
6.18×10−8) enrichment, respectively. To corroborate this, we performed partitioned 
heritability analysis to test for enrichment of local-ATAC-QTLs in explaining the heritability 
of 28 common diseases where summary statistics are available. While local-ATAC-QTLs are 
highly enriched for disease associated variants (i.e. Celiac’s disease: 6%, enrichment = 51x 
and Crohn’s disease: 7%, enrichment = 63x), the results are not statistically significant after 
multiple testing correction. However, by relaxing the FDR thresholding for defining local-
ATAC-QTLs, we found a general trend of increased proportion of heritability explained and 
statistical significance, and a decrease in enrichment, especially in autoimmune diseases 
(Fig. 4h; Methods). In fact, all SNP-containing ATAC-peaks (corresponding to FDR < 1) 
account for a statistically significant proportion of the heritability for all autoimmune 
diseases (> 22%, Bonferroni-corrected P-value < 1.3×10−2, Fig. 4h; Methods). For example, 
rs17293632 (NC_000015.10:g.67442596C>T) has been associated with Crohn’s disease and 
IBD52 and is located in the first intron of SMAD3, a gene that encodes for a transcription 
factor involved in the TGF-β signaling pathway that regulates T cell activation and 
metabolism53. This SNP disrupts a consensus BATF binding site at a conserved position 
(deltaSVM=-12.72), and results in decreased chromatin accessibility in individuals that carry 
the alternate allele (Fig. 4i).
Together, these results suggest that when the accessibility of ATAC-peaks is affected by 
local-ATAC-QTLs residing within peaks, this often involves the disruption of TF binding, 
even though the SNPs almost always reside outside of the core TF binding site. Moreover, 
local-ATAC-QTLs in stimulated CD4+ cells are enriched for autoimmune disease loci, both 
in the number of overlaps and proportion of heritability explained.
Genetic determinants of chromatin co-accessibility
We next tested if the effect of each local-ATAC-QTL could be propagated to co-accessible 
peaks, for example through 3D chromatin organization, and thus have effects on multiple 
cis-regulatory elements simultaneously. We first estimated the heritability of ATAC-peaks 
using SNPs +/− 500 kb of each peak. As expected, local-ATAC-peaks (2,444/3,318 that 
converged) were more heritable (mean h2 = 0.22) than all ATAC-peaks (Fig. 5a). Co-
accessible peaks were also more heritable than all ATAC-peaks, both those containing SNPs 
(mean h2 = 0.44 vs. mean h2 = 0.04) and those that do not (mean h2 = 0.10 vs. mean h2 = 
0.04). Excluding the 3,318 local-ATAC-peaks, we identified 382 ATAC-peaks that were 
associated with a local-ATAC-QTL (RASQUAL, P-value < 1.27×10−4, permutation FDR < 
0.05) located +/− 500 kb from the peak. We term each associated SNP a distal-ATAC-QTL 
and each associated peak a distal-ATAC-peak (Fig. 2b). Consistent with the heritability 
analysis, distal-ATAC-QTLs imparted the strongest effects on co-accessible peak (Fig. 5b 
and Supplementary Tables 2, 3).
Co-accessible peaks and co-accessible distal-ATAC-peaks are both more likely to overlap 
Thstim super enhancers than randomly shuffled super enhancers41. The effect is stronger in 
co-accessible distal-ATAC-peaks (6-fold vs. 4-fold) (Fig. 5c). In an example, rs10882660 
Gate et al. Page 7
Nat Genet. Author manuscript; available in PMC 2019 January 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
(NC_000010.10:g.97517949A>G) is simultaneously a local- and distal-ATAC-QTL for a 
pair of co-accessible peaks residing in the 1st and 2nd introns of ectonucleoside triphosphate 
diphosphohydrolase I (ENTPD1) and a Hi-C contact domain (Fig. 5d). ENTPD1 encodes a 
protein that is one of the dominant drivers of hydrolysis of ATP and ADP in Tregs cells, 
whose expression can lead to tumor growth in mouse models54–57. These results and 
example suggest a model where local-ATAC-QTLs residing within peaks could also distally 
affect co-accessible peaks likely reflecting shared genetic effects on pairs of cis-regulatory 
elements.
Linking variation in chromatin state and gene expression
We hypothesized that variants affecting chromatin accessibility (local-ATAC-QTLs) would – 
in some cases – also impact the transcription of the genes controlled through these 
regulatory regions, and thus provide an important link between variant and target.
To test this hypothesis, we assessed if local-ATAC-QTLs are also associated with gene 
expression in stimulated CD4+ T cells, measured by RNA-seq from 95 donors (92 from an 
aliquot of the same cells with matching ATAC-seq data). After accounting for covariates and 
principal components for expression heterogeneity (Supplementary Tables 3, 4), we 
identified 424 genes significantly associated with at least one of 6,903 local-ATAC-QTLs 
located +/− 500 kb from the center of each gene (RASQUAL, P-value < 1.65×10−3, 
permutation FDR < 0.05, Fig. 6a, and Supplementary Table 8). The 383 best-associated 
SNPs are eQTLs, and we term the corresponding 424 genes eGenes (Fig. 2b, right). We 
estimate that 30% of local-ATAC-QTLs are also eQTLs (with a procedure to estimate the 
proportion of null hypotheses; Methods), consistent with previous reports in lymphoblastoid 
cell lines19,21. Considering all genetic variants located +/− 500 kb from the center of each 
eGene, we found 191/424 genes to be significantly heritable (GCTA FDR < 0.05), with the 
eQTL explaining on average 68% of the heritability (Fig. 6b and Supplementary Table 9). 
The lower estimates of explained heritability than local-ATAC-peaks suggests that the 
genetic control of gene expression may involve more than one SNP and cis-regulatory 
element in some cases.
We next examined the sharing of genetic effects between local-ATAC-peaks and eGenes 
using a bivariate linear mixed model45 and mediation analysis58. Among the 383 SNPs that 
are simultaneously associated with chromatin accessibility (as local-ATAC-QTLs) and gene 
expression (as eQTLs), 286 have effect sizes in the same direction (Spearman ρ = 0.73) 
indicative of activating effects, while 138 have effect sizes in the opposite direction 
indicative of repressive effects (Spearman ρ = −0.69) (Fig. 6c). Because of limited sample 
size, measuring the genetic correlation for individual pairs of local-ATAC-peaks and eGenes 
is likely under powered. However, the distribution of genetic correlations for 161 pairs of 
local-ATAC-peaks and eGenes that converged (inverse variance weighted average of 0.66) 
was significantly higher than both randomly sampled (inverse variance weighted average of 
0.23, Kolmogorov-Smirnov P-value < 4.32×10−10) and permuted ATAC-peaks (inverse 
variance weighted average of 0.07, Kolmogorov-Smirnov P-value < 1.68×10−10) 
(Supplementary Fig. 18 and Supplementary Table 10). This is corroborated by mediation 
analysis where the genetic effects on 21/424 eGenes were significantly mediated by the 
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corresponding local-ATAC-peaks (FDR < 0.1, Fig. 6d) and the high correlation of the 
mediation effects and the inverse variance weighted genetic correlation (Pearson R = 0.52, 
P-value < 1.2×10−12, Supplementary Fig. 19). For example, consider the locus spanning 
FADS1 and FADS2, genes that encode two fatty acid desaturases (FADS) that regulate 
inflammation, promote cancer development, and impact dermal and intestinal ulcerations (in 
FADS2 knockout mice)59–62. Before conditioning on rs174575 (NC_000011.10:g.
61602003C>G), an eQTL for FADS2 and a local-ATAC-QTL for 
chr11:61,601,708-61,602,451, FADS2 expression and accessibility of ATAC-peak 
chr11:61,601,708-61,602,451 are correlated (R2 = 0.31, P-value < 8.25×10−9) and after 
conditioning there is no longer a correlation (R2 = 0.08, P-value < 6.1×10−3) (Fig. 6e). 
Similarly, after conditioning on rs174561 (NC_000011.10:g.61582708T>C), FADS1 
expression is no longer correlated with accessibility of ATAC-peak 
chr11:61,582,207-61,584,717 (before conditioning: R2 = 0.2, P-value < 8.74×10−6; after 
conditioning: R2 = 0.01, P-value < 0.3) (Fig. 6f). Notably, rs174561 is an eQTL for FADS1, 
a local-ATAC-QTL associated with a pair of co-accessible peaks, and has been previously 
associated with Crohn’s disease. It is also in LD with rs174537 (NC_000011.10:g.
61552680T>G, r2 = 0.82, D’ = 0.99), a SNP previously identified as an eQTL in blood63,64. 
The associated co-accessible peaks span the promoters of FADS1 and FADS2 (Fig. 6g, h). 
These results suggest that 30% of the time, genetic variants associated with chromatin 
accessibility are also associated with gene expression, and in some cases, such as the FADS1 
and FADS2 loci previously associated with Crohn’s disease, can be directionally linked 
through mediation analysis.
Discussion
Although variability in gene expression has been extensively characterized, variability in 
chromatin state has been challenging to study in primary cells. To this end, we analyzed 
ATAC-seq profiles in primary CD4+ T cells from five individuals at rest and in response to 
stimulation. We found global remodeling of accessible chromatin after stimulation, with a 
significantly higher number of accessible regions overlapping a large proportion (12 - 28%) 
of SNPs associated with autoimmune diseases and different T cell enhancer subsets (e.g. 
Tregs, Th17, etc).
Due to these initial observations, we dissected the relationship between genetic variation and 
variability in chromatin accessibility in a physiologically-relevant system, stimulated CD4+ 
cells. Variation across 105 individuals highlights four inter-related phenomena. First, 
accessible regions co-vary across the genome of an individual (co-accessibility), reflective of 
the 3D structure of the genome. At individual peak resolution, ~2% of ATAC-peaks are co-
accessible, especially if they are within the same Hi-C contact domain, and these are more 
likely to overlap T cell enhancers, pioneering factors, and “pairs” of regulatory regions, 
including super-enhancers. These results suggest that co-accessibility between pairs of peaks 
may be determined by the 3D conformation of the genome and may correspond to 
coordinated regulation of multiple cis-regulatory elements. Second, combining genetic 
variation with variation in individual peak accessibility, we identified local-ATAC-QTLs. 
Even though only a minority (5%) of local-ATAC-QTLs directly reside within the core 
binding sites of TFs, nearly half (45%) are predicted to dramatically disrupt binding at TF 
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binding sites. Moreover, even though local-ATAC-peaks are only 5% of SNP-containing 
ATAC-peaks, they overlap ~10-30% of the previously reported loci for several common 
autoimmune diseases and explain 1-7% of the disease heritability. The overwhelming 
enrichment for autoimmune disease loci among local-ATAC-peaks could be the result of 
both the increased number of features tracking cell state and the propensity for disease-
causing variants to perturb cis-regulatory elements containing key TFs active in specific cell 
types or states. Third, we found that local-ATAC-QTLs can further act distally on additional 
peaks in a 1 Mb window, with the strongest effects on ATAC-peaks that are co-accessible, 
which substantially increase their mechanistic and functional impact. Fourth, considering 
local-ATAC-QTLs in the context of variation in gene expression (by RNA-seq; 92 
overlapping individuals), we estimated that 30% of local-ATAC-QTLs are also eQTLs, with 
bivariate and mediation analyses suggesting there may be mechanistic directionality between 
these functional phenotypes.
In a manner consistent with known modes of transcriptional regulation, our approach for a 
staged analysis, testing the effects of local-ATAC-QTLs on distal-ATAC-peaks and gene 
expression, allowed us to overcome power limitations from the sample size and the technical 
and biological variability in the assays to detect hundreds of genes associated with local-
ATAC-QTLs. Despite this, there was limited power for bivariate analysis to quantify the 
shared genetic effects and establish causality for the observed association to both chromatin 
state and gene expression. These limitations will likely be overcome in future studies with 
larger sample sizes and higher sequencing depth.
Our findings, derived from large scale genetic association of quantitative chromatin and gene 
expression traits in primary human cells implicated in many diseases, provide a molecular 
framework for how disease-causing variants could alter local chromatin structure to 
modulate gene expression. With the recent advancement of single cell epigenomic65 and 
transcriptomic66,67,68 profiling, it should be possible to more directly detect context-specific 
genetic effects in a heterogeneous cell population. Future studies that use other disease-
relevant primary cells and tissues will help pinpoint causal disease variants and understand 
the regulatory mechanism underlying common disease.
Materials and Methods
Study subjects and genotyping
Healthy subjects between the ages of 18 to 56 (avg. 29.9) enrolled in the PhenoGenetic 
study8 were recruited from the Greater Boston Area and gave written informed consent for 
the studies. Individuals were excluded if they had a history of inflammatory disease, 
autoimmune disease, chronic metabolic disorders or chronic infectious disorders. 
Genotyping using the Illumina Infinium Human OmniExpress Exome BeadChips (704,808 
SNPs are common variants [MAF > 0.01] and 246,229 are part of the exomes; Illumina Inc., 
San Diego, CA) has been previously described18. The genotyping success rate was at least 
97%. We applied rigorous subject and SNP quality control (QC) that includes: (1) gender 
misidentification; (2) subject relatedness; (3) Hardy-Weinberg Equilibrium testing; (4) use 
concordance to infer SNP quality; (5) genotype call rate; (6) heterozygosity outlier; and (7) 
mismatch detection using SNP overlapping reads from ATAC-seq and RNA-seq. We 
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excluded 1,987 SNPs with a call rate < 95%, 459 SNPs with Hardy-Weinberg equilibrium P-
value < 10−6, and 63,781 SNPs with MAF < 1% from the 704,808 common SNPs (a total of 
66,461 SNPs excluded). Principal component analysis of genotypes from all individuals 
used in the study are shown in Supplementary Figure S6.
We used the IMPUTE2 software (version: 2.3.2) to impute the post-QC genotyped markers 
from the entire ImmVar cohort (N = 688) using reference haplotype panels from the 1000 
Genomes Project (The 1000 Genomes Project Consortium Phase III) that contain a total of 
37.9 Million SNPs in 2,504 individuals with ancestries from West Africa, East Asia, and 
Europe. After genotype imputation, we extracted the genotypes for 105 individuals assayed 
for chromatin accessibility and gene expression. Additional removal of SNPs with MAF < 
0.05 in our cohort resulted in 4,558,693 and 4,421,936 common variants tested for 
chromatin accessibility and gene expression assays, respectively.
Preparation and activation of primary human CD4+ T cells
CD4+ T cells were isolated and stimulated as previously described10. Briefly, CD4+ T cells 
were isolated from whole blood by negative selection using RosetteSep human CD4+ T cell 
enrichment cocktail (STEMCELL Technologies Inc., Vancouver, BC) and RosetteSep 
density medium gradient centrifugation. Isolated CD4+ T cells were placed in freezing 
container at −80°C for overnight, and then moved into a liquid nitrogen tank for long-term 
storage. On the day of activation, CD4+ T cells were thawed in a 37°C water bath, counted 
and resuspended in RPMI-1640 supplemented with 10% FCS, and plated at 50,000 cells per 
well in a 96 well round-bottom plate. Cells were either left untreated or stimulated with 
beads conjugated with anti-CD3 and anti-CD28 antibodies (Dynabeads, Invitrogen 
#11131D, Life Technologies) at a cell:bead ratio of 1:1 for 48 hours, a time point we 
previously found to maximize the gene expression response in CD4+ T cells. At each time 
point, cells were further purified by a second step positive selection with CD4+ Dynabeads 
(Invitrogen #11145D, Life Technologies).
ATAC-seq profiling
ATAC-seq profiles were collected for 139 individuals (Supplementary Table 4). We 
performed ATAC-seq as previously described32, with a modification in the lysis buffer to 
reduce mitochondrial DNA contamination. 200,000 purified CD4+ T cells were lysed with 
cold lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2 and 0.03% 
tween20). Immediately after lysis, nuclei were spun at 500g for 8 minutes at 4°C. After 
pelleting the nuclei, we carefully removed the supernatant and resuspended the nuclei with 
Tn5 transposase reaction mix (25 ul 2X TD buffer, 2.5 ul Tn5 transposase, and 22.5 ul 
nuclease-free water) (Illumina Inc). The transposition reaction was performed at 37°C for 30 
minutes. Immediately after the transposition reaction, DNA was purified using a Qiagen 
MinElute kit. Libraries were sequenced on an Illumina HiSeq 2500 sequencer to an average 
read depth of 42 million (+/− 38 million) per sample (Supplementary Fig. S2), with low 
mtDNA contamination (0.30 – 5.39%, 1.96% on average), low rates of multiply mapped 
reads (6.7 – 56%, 19% on average) and a relatively high percentage of usable nuclear reads 
(60 – 92%, 79% on average).
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RNA-seq profiling
RNA-seq profiles were collected for 95 individuals, of which 92 have matching ATAC-seq 
profiles (Supplementary Table 4). RNA was isolated using Qiagen RNeasy Plus Mini Kit 
and RNA integrity was quantified by Agilent RNA 6000 Nano Kit using the Agilent 
Bioanalyzer. Purified RNA were converted to RNA-seq libraries using a previously 
published protocol69, where reverse transcription was carried out based on the SMART 
template switching method and the resulting cDNA was further tagmented and PCR 
amplified using Nextera XT DNA Sample kit (Illumina) to add the Illumina sequencing 
adaptors. Samples were sequenced on Illumina HiSeq 2500 to an average depth of 16.9 
million reads per sample (+/− 8.7 million).
In situ Hi-C
CD4+ T cells were isolated from commercially available fresh blood of healthy individuals 
(Research Blood Components). CD4+ T cells were stimulated for 48 hours with beads 
conjugated with anti-CD3 and anti-CD28 antibodies. In situ Hi-C was performed on the pool 
of donors as previously described40. Cells were crosslinked with 1% formaldehyde for 10 
min at room temperature. After nuclei permeabilization, DNA was digested with MboI and 
digested fragments were labeled using biotinylated d-ATP and ligated. After reverse 
crosslinking, ligated DNA was purified and sheared to ~400 bp. Biotin labeled DNA 
fragments were then pulled down with streptavidin beads and prepped for Illumina 
sequencing40. The final libraries were sequenced using Illumina HiSeq and NextSeq to 
produce ~3.5 billion 100bp paired-end reads.
Alignment of ATAC-seq reads
25bp ATAC-seq reads were aligned to the human genome assembly (hg19) with the 
Burrows-Wheeler Aligner-MEM (version: 0.7.12)70. For each sample, multiply-mapped 
reads were filtered using Samtools “view”71 with option “-F 4” and mitochondrial reads 
were filtered out using BEDtools (function intersectBed)72. After filtering, we had a median 
of 37 million (MAD +/− 13 million) reads per sample.
ATAC-seq peak identification
Filtered ATAC-seq reads from six matched samples (five individuals, of which one 
individual was repeated) for Th and Thstim cells were merged (separately for Th and Thstim 
cells) using the Samtools function “merge”71. Peaks were called on the respective Th and 
Thstim merged bam files using MACS2 –callpeak (with parameters: –nomodel, –extsize 200, 
and –shift 100), resulting in 36,486 Th peaks with an average width of 520 bp (+/− 319 bp) 
and 52,154 Thstim peaks with an average width of 483 bp (+/− 344 bp) (Benjamini-Hochberg 
FDR < 0.05)73. The Th and Thstim peaks were further merged (using the BEDtools “merge” 
function), to a total of 63,763 jointly called peaks. BEDtools “coverage”72 was used to 
create a 63,763 (peaks) x 12 (6 samples by 2 conditions) input matrix used for detecting 
differentially accessible peaks. Differentially accessible peaks between Th and Thstim cells 
were identified using the DESeq2 R package (version 3.2)74, with 8,298 Th-specific peaks 
(FDR < 0.05, more accessibility in Th cells), 28,017 Thstim-specific peaks (FDR < 0.05, 
more accessibility in Thstim), and 27,446 shared peaks (FDR > 0.05).
Gate et al. Page 12
Nat Genet. Author manuscript; available in PMC 2019 January 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
For the co-accessibility and genetic analyses, 4.2 billion filtered ATAC-seq reads from 105 
Thstim samples were merged to call 167,140 peaks (FDR < 0.05) using the same parameters 
as previously described, at an average peak size of 642 bp (+/− 512 bp). Coverage for each 
peak over all 105 samples was computed.
Percentage of peaks overlapping transcription factor binding motifs
Percentages of MACS2 called peaks overlapping TF binding motifs were computed using 
the default setting in the Homer suite75 function findMotifsGenome.pl (with genome 
reference hg19, option –size given). For co-accessible peaks and local-ATAC-peaks, 
background overlap percentages were computed using randomly sampled genomic regions 
preserving the width of each peak to assess the expected TF motif enrichment.
Transcription factor footprinting
Using the Homer suite tool annotatePeaks75, and options –m and –mbed, we found all 
instances of BATF, ISRE, BATF/IRF, ETS1, and CTCF motifs in shared, Th-specific and 
Thstim-specific peaks. Next, we determined the per-base coverage +/− 1 kb around the center 
of the motif using BEDtools “coverage”, only counting reads that begin at a given location 
in order to prevent smoothing of the chromatin accessibility signal, and splitting the reads 
into those that map to the same or opposite strand as the motif to account for biases in 
ATAC-seq requiring two transposases (i.e. one at a TF binding site and another at a 
nucleosome accessible region). For each TF footprint, we generated a matrix with the 
number of rows equal to the number of instances of the motif by 4,000 columns quantifying 
coverage: +/− 1kb from the same and opposite strand and as the motif. Final TF footprints 
were derived from median normalized reads.
Outlier analysis and sample mix-up analysis
ATAC-seq samples were further filter if the samples contained a minimum of 8 million QC-
passed reads (median of 37 million, MAD +/−13 million) and were highly correlated with 
other samples (mean Pearson R > 0.68). ATAC-seq and RNA-seq profiles from the 105 
individuals were further filtered to identify sample mix-ups. We used the software 
VerifyBamID76 to match each ATAC-seq and RNA-seq sample with the genotyping profile 
with the highest fIBD score. Samples with designated labels not matching the VerifyBamID 
predicted genotyping labels were flagged as sample mix-ups. We switched the designated 
label to the predicted label for cases where the fIBD > 90%. 15 out of the 139 total ATAC-
seq samples were re-labeled and four out of the 110 total RNA-seq samples were re-labeled. 
For the ATAC-seq samples: 18 do not have genotypes, three are outliers, one did not match 
anyone. For the 110 RNA-seq samples: eight samples do not have genotypes, five are 
outliers, one did not match anyone. 111 ATAC-seq samples and 96 RNA-seq samples were 
used in the final analysis after filtering. In the response to activation study, there were five 
people total, 1 person was repeated for a total of six samples, none were genotyped.
Genetic association analysis of ATAC-peaks
Genetic association analysis was performed on 105 samples of European descent 
(Supplementary Fig. S6) by running RASQUAL43 on the 167,140 peaks identified in Thstim 
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cells and 4,558,693 imputed genetic variants, testing variants within a 1 Mb window of each 
ATAC-peak, and filtering for a minor allele frequency of greater than 5% using uniquely 
mapped nuclear reads per individual. Sex and ten principal components (Supplementary 
Table 4) were included as covariates to minimize the effects of confounding factors. Using 
the RASQUAL “-r” option, 10 permutations were generated for each ATAC-peak. For local-
ATAC-peak analysis, association statistics for 158,613 peak-SNP pairs where the SNP 
resides within the peak are compared. For distal-ATAC-peak analysis, association statistics 
for peak-SNP pairs where the SNP does not reside within the peak are compared. In each 
case, empirical P-values and the corresponding false discovery rates were computed using 
the R qvalue44 package to detect a total of 3,318 local -ATAC-peaks (FDR < 0.05) and 382 
distal-ATAC-peaks (FDR < 0.05).
Hi-C data analysis
The sequenced reads were analyzed using the Juicer pipeline77. We sequenced 
2,940,433,604 Hi-C read pairs in stimulated T cells. Loci were assigned to A and B 
compartments at 500 kB resolution. Contact domains were annotated using the Arrowhead 
algorithm with default Juicer parameters at 5kB for stimulated T cells. This yielded a list of 
4,008 domains in stimulated T cells at MAPQ > 30. We also ran Arrowhead with these same 
respective parameters on MAPQ > 0 Hi-C maps, which yielded a list of 4,419 domains in 
stimulated T cells. The Hi-C maps and feature annotations were visualized using the 
Juicebox software77.
Determination of distance from ATAC-peak to contact domains
We determined the distance from each SNP-containing ATAC-peak to the middle of the 
closest contact domain. We analyzed the following features: (1) all SNP-containing ATAC-
peaks; (2) local-ATAC-peaks; and all SNP-containing ATAC-peaks and local-ATAC-peaks 
containing (3) BATF, (4) ETS1, or (5) CTCF motifs. Homer annotatePeaks ‘–mbed’75 
option was used to identify SNP-containing ATAC-peaks and local-ATAC-peaks that contain 
BATF, ETS1, and CTCF motifs, as previously described. We normalized the distances from 
each peak to the closest domain by the length of the domain. In order to determine that the 
distribution of the distance between a given peak and a contact domain is different than the 
null distribution, we kept the length of each contact domain constant and shuffled the 
positions of the contact domain. The distances from each peak to the contact domain were 
binned into 30 bins and divided by the binned distances between a given peak and the 
shuffled contact domains to determine enrichment at each position.
Co-accessible peak analysis
To identify co-accessible peaks, we computed the correlation between every pair of 167,140 
ATAC-peaks within 1.5 Mb of each other using a linear regression model implemented by 
Matrix eQTL78. We first normalized the ATAC-peaks by (1) removing sequencing depth bias 
using median normalization, (2) standardizing the matrix by subtracting out the mean and 
dividing by the standard deviation for each peak; and (3) quantile normalizing the matrix79. 
Adjusting for sex and 15 principal components, we used Matrix eQTL to identify 2,158 
pairs of co-accessible peaks (1,809 unique ATAC-peaks, FDR < 0.05). We reran the analysis 
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using 10 permuted datasets generated by shuffling the peak counts for an individual to 
obtain a distribution of permuted P-values. The qvalue package was used to obtain empirical 
P-values and false discovery rates44.
RNA-seq analysis
25bp paired end RNA-seq reads were aligned to the hg19 using UCSC transcriptome 
annotations. Expression levels (expected counts) were determined using RSEM79. We 
applied trimmed mean of M-values normalization method (TMM) to the expected counts 
using the edgeR package and kept genes that had TMM count > 1 in at least 75% of the 
samples. For the mapping of eQTLs, we inputted expected counts for filtered genes into 
RASQUAL43. For the heritability analyses, we used log-transformed TMM counts of 
filtered genes in order to fit linear mixed models.
Percentage of GWAS loci overlapping
The GREGOR suite63 was used for calculating the percentage of GWAS loci in features of 
interest: (1) peaks differentially accessible in Th and Thstim cells, (2) co-accessible peaks, 
(3) SNP-containing peaks, and (4) local-ATAC-peaks. GWAS loci in the National Human 
Genome Research Institute GWAS catalogue as of November 2016 were overlapped. For 
local-ATAC-peaks, peaks were randomly permuted, while retaining the width of each peak 
to assess the expected GWAS enrichment.
Partitioned heritability analysis
Partitioned heritability analysis was performed using LD Score80. Summary statics for all 
SNPs for 28 GWAS (Alzheimer, anorexia, autism, bipolar disorder, BMI, celiac, coronary 
artery disease, crohn’s disease, DS, ever smoked fasting glucose, HDL, IBD, LDL, lupus, 
multiple sclerosis, neuroticism, primary biliary cirrhosis, rheumatoid arthritis, schizophrenia, 
SWB, triglycerides, type 1 diabetes, type 2 diabetes, ulcerative colitis, years of education 1, 
and years of education 2) phenotypes were downloaded from the Broad Institute (see URLs). 
Local-ATAC-QTLs were thresholded at FDR < 0.05, FDR < 0.1, FDR < 0.2, FDR < 0.5, and 
all tested SNPs. Using SNPs at each FDR threshold, annotation files and LD Scores were 
estimated for all 28 GWAS phenotypes using ‘ldsc.py –l2′. Finally, to calculate the 
partitioned heritability across each phenotype, including our local-ATAC-QTLs at each FDR 
threshold, respectively, ‘ldsc.py –h2′ was run.
Percentage overlapping T cell annotations
Using the Homer suite annotatePeaks.pl with the –genomeOntology option75, we calculated 
how many of the Thstim-specific peaks, co-accessible peaks, SNP-containing peaks, and 
local-ATAC-peaks fall T cell enhancers18. For co-accessible peaks, SNP-containing peaks, 
and local-ATAC-peaks peak subsets, background overlap was calculated using randomly 
sampled genomic regions preserving the width of each peak to assess the expected T cell 
enrichment.
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Proportion in super-enhancer regions
Using the BEDtools “intersect” function, we calculated how many of the co-accessible 
peaks and co-accessible local-ATAC-peaks are also in stimulated Th super-enhancers (as 
reported in Hinsz et al.41). Background proportions were computed using randomly sampled 
genomic regions preserving the length of each super enhancer.
Proportion co-accessible peaks in known regulatory elements
Using the BEDtools “intersect” function72, we annotated each peak in our unique pairs of 
co-accessible peaks as residing in a known Thstim super enhancer (as reported in Hinsz et al.
41), promoter (as reported in Fahr et al.18), and T cell promoter (as reported in Fahr et al.18). 
We determined if each peak in a pair of peaks resided in a promoter and a promoter, 
promoter and a super enhancer, a promoter and an enhancer, an enhancer and an enhancer, 
an enhancer and a super enhancer, and a super enhancer and a super enhancer. As 
background (‘non co-accessible peak’), we used pairs of ATAC-peaks with P-value > 0.9, 
sampled to the same number as co-accessible peaks, and performed the same analysis.
Gkm-SVM and deltaSVM
We ran gkm-SVM46,47 on 24,745 300bp ATAC-peaks centered on MACS summits using 
default parameters and an equal size GC matched negative set, excluding from training any 
region containing a SNP to be scored by deltaSVM, and repeated with 5 independent 
negative sets, and averaged the deltaSVM predictions, as previously described48. We then 
calculated deltaSVM for each SNP in a local-ATAC-peak, scoring 903 SNPs in 888 loci. We 
find a Pearson correlation of R=0.627 between ATAC-QTL beta and the largest deltaSVM 
SNP. 777 of the peak P-value SNPs had the largest deltaSVM, but 111 flanking SNPs scored 
more highly than the peak P-value SNP and disrupt immune associated TF binding sites. 
While the gkm-SVM weights fully specify the deltaSVM score, for interpretation we 
associated the large gkm-SVM weights with the most similar TF PWM from a catalog of 
JASPAR, Transfac, Uniprobe, and Homer motifs.
Heritability of gene expression and ATAC-peaks
For the univariate analyses, restricted maximum likelihood heritability (h2) estimates were 
calculated using GCTA software45 with algorithm 1 and no constraints on heritability (i.e., 
h2 can be less than 0), while the bivariate analysis was run constrained. For the gene 
expression heritability analysis, where gene expression was residualized for 12 principal 
components and sex, and ATAC-peak heritability analysis, where ATAC-peaks were 
residualized for 10 principal components and sex, we used genotypes +/− 500 kb from the 
transcription start site of the gene and center of each ATAC-peak, respectively. Of the 64,188 
SNP-containing ATAC-peaks and 3,318 local-ATAC-peaks, 32,317 and 2,444 converged 
respectively. The bivariate GCTA analysis used genotypes +/− 500kb from the transcription 
start site of the gene. Randomly sampled ATAC-peaks (non local-ATAC-peaks) and 
permuted ATAC-peaks were plotted as background at the same number of the tested local-
ATAC-peaks (N=161, standard errors < 1).
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Mediation of eGenes by local-ATAC-peaks
Pairs of local-ATAC-peak and eGenes were matched through their shared eQTL. Our 
normalized ATAC-peak matrix, as previously described (Methods), was further adjusted for 
gender and 10 principal components was used as input local-ATAC-peaks. Normalized gene 
expression matrix, as previously described (Methods), was further adjusted for gender and 
12 principal components used as input as input for our eGenes. For each eQTL a 92 x three 
matrix was formatted. Each row in the matrix corresponded to an individual and each 
column corresponded to (1) eQTL genotype, (2) normalized local-ATAC-peak, and (3) 
normalized eGene. First, we regressed local-ATAC-peak ~ eQTL. Second, we regressed 
eGene ~ eQTL + local-ATAC-peak. To test for statistically significant mediation effects, the 
mediator package58 ‘mediate’ function was called using both regression models as input.
Conditioning on eQTL
For each eQTL, the 92 x three matrix that was previously described (Methods) was used as 
input. To capture the effects of the eQTL, we regressed the eGene ~ local-ATAC-peak. To 
capture the effects after conditioning on the eQTL, we regressed the residuals of eGene ~ 
eQTL to the local-ATAC-peak.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Changes in chromatin state in human T cell activation
(a) Experimental overview (left) and schematic of nomenclature (right). (b) Differential 
chromatin accessibility. Regions of open chromatin (columns) in six samples (rows) before 
(top, Th-specific) and 48hr after (bottom, Thstim-specific) activation of primary T cells with 
anti-CD3/CD28 antibodies. (c) Overlap with previously annotated T cell enhancers. For each 
annotation, expected (x-axis) vs. observed (y-axis) percentages of annotated features 
overlapping Th-specific (left), Thstim-specific (center) and shared peaks (right). (d) Overlap 
with GWAS variants. For each phenotype or disease, expected (x-axis) vs. observed (y-axis) 
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percentages of GWAS loci overlapping Th-specific (left), Thstim-specific (center), or shared 
(right) peaks.
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Figure 2. Changes in transcription factor enrichment in response to T cell activation
(a) Transcription factor motif enrichment. Expected (x-axis) vs. observed (y-axis) 
percentages of Th-specific (left), Thstim-specific (center), or shared (right) peaks overlapping 
each TF binding site annotation. (b-d) TF footprinting. For each TF motif (as defined in 
ENCODE63), nucleotide resolution average chromatin accessibility (y-axis) in Th (purple) 
or Thstim (red) cells along the TF binding site (x-axis; log(bp from center of each TF motif)). 
Aggregated locations are defined as (b) Thstim-specific peaks overlapping BATF, ISRE, and 
BATF/IRF motifs (three left panels) and shared peaks overlapping CTCF binding sites (right 
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panel), (c) Th-specific (left) and Thstim-specific (right) peaks overlapping ETS1 binding 
sites, and (d) Th-specific peaks overlapping ETS1/RUNX combinatorial binding sites.
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Figure 3. Inter-individual chromatin co-accessibility
(a) Overview of T cell activation for 105 ATAC-seq and 95 RNA-seq samples. (b) 
Schematic of nomenclature for co-accessible peaks, SNP-containing peaks, local-ATAC-
QTLs, distal-ATAC-QTLs, and eQTLs. Dashed lines denote a correlation between co-
accessible peaks and solid lines denote a genetic association. (c) Megabase scale correlation 
of chromatin accessibility across 105 individuals. Heat map shows the pairwise Pearson 
correlation of chromatin accessibility between 1 Mb bins (row, column) for Chr 1. (d) 
Pearson correlation of Hi-C interactions at 1 Mb resolution for Chr 1. (e) Histogram of 
distances between significantly co-accessible peaks (pink) and random permuted peaks 
(grey). (f) Co-accessible peaks overlap with Hi-C domains. Q-Q plot of linear regression P-
values for pairs of peaks residing in (blue) or out (red) of the same Hi-C domain. (g) Pairs of 
co-accessible peaks overlapping with multiple cis-regulatory regions. A cartoon depiction 
(top) of co-accessible peaks in promoters (green), enhancers (blue), and super enhancers 
(orange). Proportion (y-axis) of pairs of co-accessible peaks and non-co-accessible peaks 
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overlapping pairs of annotated cis-regulatory elements (right). (h) Proportion of co-
accessible peaks overlapping super-enhancers or randomly shuffled background.
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Figure 4. Genetic variants that affect chromatin states in human T cell activation
(a) Q-Q plot of linear regression P-values for all local-ATAC-QTLs (black) and local-ATAC-
QTLs binned by minor allele frequency: 0.1 > MAF > 0.05 (red), 0.2 > MAF > 0.1 (orange), 
0.3 > MAF 0.2 (yellow), 0.4 > MAF > 0.3 (green), 0.5 > MAF 0.4 (blue), and MAF > 0.05 
(black). (b) Heritability of chromatin accessibility. For each of 1,428 local-ATAC-peaks, 
coefficient of determination (R2) of the best associated local-ATAC-QTL (y-axis) vs. cis 
heritability (h2) estimated based on all genotypes +/− 500 kb of each peak (x-axis). Black 
points: significantly heritable peaks (FDR < 0.05). (c) Enrichment of local-ATAC-peaks in 
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TSS and TTS. 3,318 local-ATAC-peaks (dark pink and purple) vs. 3,318 randomly sampled 
SNP-containing ATAC-peaks (light pink and purple). (d-f) Disruption of TF binding sites by 
local-ATAC-QTLs. (d) Unsupervised TF binding site analysis of local-ATAC-peaks. Motifs 
for six TFs associated with most of the large gkmSVM weights, and the percentage of the 
overall disruption (%, bottom) explained by local-ATAC-QTLs. (e) Correlation of effect 
sizes of local-ATAC-QTLs (x-axis) vs. deltaSVM scores (y-axis). (f) Allele specificity of 
local-ATAC-QTLs. For BATF, ETS1 and CTCF motifs (as identified in ENCODE63), 
aggregated plots of mean chromatin accessibility (y-axis) of local-ATAC-peaks along the TF 
binding site (x-axis; log(bp from center of the TF motif)) for samples heterozygous (pink), 
homozygous for the high (blue) or low (green) local-ATAC-QTL alleles (g) Relation 
between contact domains and SNP-containing ATAC-peaks or local-ATAC-peaks. For 
ATAC-peaks or local-ATAC-peaks overlapping ETS1, CTCF, or BATF binding sites, 
enrichment density (y-axis) vs. distance (number of domains) of peak to nearest domain (x-
axis). Hi-C contact domain boundaries are indicated (dotted red lines). (h) Partitioned 
heritability estimates. The proportion of the heritability for 28 diseases explained 
(proportion: left, y-axis; enrichment: right, y-axis) captured by local-ATAC-QTLs called at 
different FDR thresholds (x-axis). (i) Effects of local-ATAC-QTL rs17293632 on the 
accessibility of the corresponding BATF containing local-ATAC-peak on chromosome 15. 
ATAC-seq profiles were aggregated per rs17293632 genotypes (black: homozygous major 
allele, light blue: heterozygous, red: homozygous minor allele).
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Figure 5. Genetic determinants of co-accessible peaks
(a) Distribution of the heritability explained by SNPs +/− 500 kb of ATAC-peaks. Local-
ATAC-peaks (olive). SNP-containing co-accessible peaks (blue). Co-accessible peaks 
without a SNP (purple). SNP-containing ATAC-peaks (green). ATAC-peaks without a SNP 
(red). (b) Q-Q plots of the linear regression P-values of distal-ATAC-peaks that are single 
peaks (red: co-accessibility FDR > 0.5), or co-accessible peaks called at various significance 
cutoffs (light blue: 0.2 < FDR < 0.5, medium blue: 0.05 < FDR < 0.2, dark blue: FDR < 
0.05). The cartoons (upper left corner) depict the distal-ATAC-QTL association for single 
peaks (left cartoon; red line is the association plotted) and distal-ATAC-QTL association for 
co-accessible peaks (right cartoon; blue line is the association plotted; upper dashed line is 
the co-accessible peak at various significance cutoffs). (c) Proportion of co-accessible distal-
ATAC-peaks overlapping super-enhancers or randomly shuffled background. (d) An 
example of a genetic variant (rs10882660) residing in the first intron in ENTPD1, associated 
locally (in purple) and distally (in yellow) to ATAC-peaks. The local and distal-ATAC-peaks 
are co-accessible (dotted line) and reside in a Hi-C contact domain (grey). ATAC-seq 
profiles were aggregated for individuals of different rs10882660 genotypes (black: 
homozygous major allele, light blue: heterozygous, red: homozygous minor allele).
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Figure 6. Association of chromatin accessibility and gene expression
(a) eQTLs. Q-Q plot of associations between local-ATAC-QTLs (black) or all SNPs (red) 
and expression of genes +/− 500kb. (b) Heritability of gene expression. For each of 191 
eGenes, coefficient of determination (R2) of the best associated eQTL (y-axis) vs. 
heritability (h2) of all variants +/− 500 kb of each gene (x-axis). Black points: significantly 
heritable peaks (FDR < 0.05). (c) Correlation of effect sizes between local-ATAC-QTLs (x-
axis) and eQTLs (y-axis). (d) Mediation of eGenes. Average causal mediation effect 
estimates (y-axis) and average direct effect estimates (x-axis) for local-ATAC-peaks 
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(mediator) and eGenes (outcome variable) sharing a SNP (instrument variable). FDR < 0.1 
local-ATAC-peaks are colored in black. (e,f) Examples of gene expression conditioned on 
chromatin accessibility. (e) FADS2 expression (y-axis) vs. chromatin accessibility at 
chr11:61,601,708-61,602,451 (x-axis) before (left) and after (right) conditioning on 
rs174575. (f) FADS1 expression (y-axis) vs. chromatin accessibility at 
chr11:61,582,207-61,584,717 (x-axis) before (left) and after (right) conditioning, colored by 
rs174561 genotypes. (g,h) ATAC-seq (top) and RNA-seq (bottom) profiles were aggregated 
for individuals of different (g) rs174561 and (h) rs174575 genotypes (black: homozygous 
major allele, light blue: heterozygous, red: homozygous minor allele).
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